PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC10137466::ACT000405

BC

Evidence text

Paper-level observation

a dose-dependent increase in the DCFH positive ratio was also observed in the same cancer cells treated with BC, reaching 28.5%, 61.57%, and 89.38% after 24 h exposure to 4, 6, and 8 µg/mL of BC, respectively.
textConfidence: medium

Assay observation

Activity
Anticancer
Subtype
Cytotoxic
Measure
other
Comparator
=
Raw observation
28.5%
Normalized measurement
=28.5%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Homo sapiens
Assay method
Not reported by source
Sequence
Not reported by source
Standardization
insufficient information

Source publication

Novel Property Cytotoxicity and Mechanism of Food Preservative Brevilaterins against Human Gastric Cancer Cells

Foods · 2023

DOI 10.3390/foods12081732 PMC10137466
Parent mention

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.